Publications
Explore 748 academic publications
The Jackknife, the Bootstrap and Other Resampling Plans
The Jackknife Estimate of Bias The Jackknife Estimate of Variance Bias of the Jackknife Variance Estimate The Bootstrap The Infinitesimal Jackknife The Delta Method and the Infl...
Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds
The average lengths of bonds involving the elements H, B, C, N, O, F, Si, P, S, Cl, As, Se, Br, Te, and l in organic compounds are reported.
Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999−2000: A National Reconnaissance
To provide the first nationwide reconnaissance of the occurrence of pharmaceuticals, hormones, and other organic wastewater contaminants (OWCs) in water resources, the U.S. Geol...
An introduction to computing with neural nets
Artificial neural net models have been studied for many years in the hope of achieving human-like performance in the fields of speech and image recognition. These models are com...
Actual Minds, Possible Worlds
Preface PART 1: TWO NATURAL KINDS 1. Approaching the Literary 2. Two Modes of Thought 3. Possible Castles PART 2: LANGUAGE AND REALITY 4. The Transactional Self 5. The Inspirati...
Circulating microRNAs as stable blood-based markers for cancer detection
Improved approaches for the detection of common epithelial malignancies are urgently needed to reduce the worldwide morbidity and mortality caused by cancer. MicroRNAs (miRNAs) ...
Adherence to Medication
The full benefit of many effective medications will be achieved only if patients adhere to prescribed treatment regimens. Unfortunately, applying terms such as "noncompliant" an...
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Although humans have been exposed to airborne nanosized particles (NSPs; < 100 nm) throughout their evolutionary stages, such exposure has increased dramatically over the last c...
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Vemurafenib produced improved rates of overall and progression-free survival in patients with previously untreated melanoma with the BRAF V600E mutation. (Funded by Hoffmann-La ...